首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于政策工具视角的我国罕见病领域政策文本分析
引用本文:牟燕,宋奎勐,吴敏,何有琴,甄天民.基于政策工具视角的我国罕见病领域政策文本分析[J].中国卫生政策研究,2021,14(1):17-23.
作者姓名:牟燕  宋奎勐  吴敏  何有琴  甄天民
作者单位:山东第一医科大学(山东省医学科学院)医疗保障学院(山东省医疗保障研究院) 山东济南 250062;山东省医药卫生科技信息研究所 山东济南 250062
基金项目:山东第一医科大学学术提升计划;山东省医学科学院医药卫生科技创新工程;山东省医药卫生科技发展计划项目(2019WS191)
摘    要:目的:总结我国罕见病领域相关政策的关键要素及不足,为我国罕见病领域后续政策的制定与完善提供参考。方法:采用内容分析法,构建“政策目标—政策工具”分析框架对我国32份国家层面的罕见病领域相关政策进行量化分析。结果:我国罕见病领域政策目标为提升罕见病药品可及性、提升罕见病诊疗水平和提高罕见病患者保障水平,应用于上述目标的政策工具比例分别为50%、44.87%和5.13%。讨论:我国罕见病领域政策目标集中在罕见病药品可及性及诊疗水平提升;相关政策工具的选择和使用存在一定失衡或缺失,环境型政策工具使用较多,需求型政策工具使用较少。建议:今后在政策设计上应加强罕见病防治与管理,促进罕见病药品的研发、上市与使用,健全罕见病保障机制,完善罕见病政策体系。

关 键 词:罕见病  政策分析  政策工具  文本分析
收稿时间:2020/11/6 0:00:00
修稿时间:2020/12/30 0:00:00

Policy text analysis of rare disease in China based on the perspective of policy tools
MU Yan,SONG Kui-meng,WU Min,HE You-qin,ZHEN Tian-min.Policy text analysis of rare disease in China based on the perspective of policy tools[J].Chinese Journal of Health Policy,2021,14(1):17-23.
Authors:MU Yan  SONG Kui-meng  WU Min  HE You-qin  ZHEN Tian-min
Institution:Shandong First Medical University & Shandong Academy of Medical Sciences, School of Healthcare Security & Shandong Healthcare Security Research Institute, Jinan Shandong 250062, China;Shandong Institute of Medicine and health Information, Jinan Shandong 250062, China
Abstract:Objective:To summarize the key factors and deficiencies of current rare disease policies of China, and to provide references for the formulation and consummation of follow-up policies. Methods:Content analysis method was used to build an analysis framework of "policy objectives and policy tools" for quantitative analysis of 32 current Chinese rare disease policies at national level. Results:The policy objectives were to improve the accessibility of rare disease drugs, improve the diagnosis and treatment of rare diseases. Policy tools used to them accounted for 50%, 44.87% and 5.13%. Discussion:The objectives of rare disease policies focus on the access to rare disease drugs and the improvement of diagnosis and treatment of rare diseases. There is a certain imbalance or deficiency in the selection and use of policy tools. Environment-oriented policy tools are used more and demand-oriented policy tools are seldom used. Suggestions:Future policy design strengthen the prevention and management of rare diseases, promote the R&D, commercialization and use of rare disease drugs, consummate the rare disease security mechanism and further improve the rare disease policy system.
Keywords:Rare diseases  Policy analysis  Policy tools  Text analysis
本文献已被 维普 等数据库收录!
点击此处可从《中国卫生政策研究》浏览原始摘要信息
点击此处可从《中国卫生政策研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号